Benzinga - by Benzinga Insights, Benzinga Staff Writer.
In a new SEC filing on February 20, it was revealed that Humke, Executive Vice President at Graco (NYSE:GGG), executed a significant exercise of company stock options.
What Happened: The latest Form 4 filing on Tuesday with the U.S. Securities and Exchange Commission uncovered Humke, Executive Vice President at Graco, exercising stock options for 0 shares of GGG. The total transaction was valued at $0.
During Tuesday's morning session, Graco shares down by 0.0%, currently priced at $88.15. Considering the current price, Humke's 0 shares have a total value of $0.
About Graco Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2023.
Graco: A Financial Overview Revenue Growth: Over the 3 months period, Graco showcased positive performance, achieving a revenue growth rate of 5.0% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Industrials sector.
Insights into Profitability:
- Gross Margin: Achieving a high gross margin of 52.93%, the company performs well in terms of cost management and profitability within its sector.
- Earnings per Share (EPS): Graco's EPS is below the industry average. The company faced challenges with a current EPS of 0.65. This suggests a potential decline in earnings.
Valuation Overview:
- Price to Earnings (P/E) Ratio: Graco's current Price to Earnings (P/E) ratio of 29.98 is higher than the industry average, indicating that the stock may be overvalued according to market sentiment.
- Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 6.91, Graco's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
- EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): Graco's EV/EBITDA ratio stands at 20.9, surpassing industry benchmarks. This places the company in a position with a higher-than-average market valuation.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
Important Transaction Codes When dissecting transactions, the focal point for investors is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of Graco's Insider Trades.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.